Daniela Josefina Cataneo-Piña
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Daniela Josefina Cataneo-Piña has a total of 64 co-authors. Here are the top co-authors by number of shared publications:
Natalia Sánchez-Garrido
National Institute of Geriatrics (N.S.-G.), Mexico City, Mexico
3 shared publicationsAdriana Bautista-Ruiz
National Institute of Respiratory Diseases (INER) (D.J.C.-P., L.A.M.-P., B.P.C.-M., A.B.-R., B.P.S.-H., I.B.-R.), Mexico City, Mexico
2 shared publicationsBlanca Patricia Sánchez-Hernández
National Institute of Respiratory Diseases (INER) (D.J.C.-P., L.A.M.-P., B.P.C.-M., A.B.-R., B.P.S.-H., I.B.-R.), Mexico City, Mexico
2 shared publicationsBrenda Paola Castillo-Marmolejo
National Institute of Respiratory Diseases (INER) (D.J.C.-P., L.A.M.-P., B.P.C.-M., A.B.-R., B.P.S.-H., I.B.-R.), Mexico City, Mexico
2 shared publicationsEduardo Ortiz-Reyes
2 shared publications- Gloria Pérez-Rubio
HLA Laboratory, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Mexico City 14080, Mexico
2 shared publications
Latest Publications
- Open Access
- 30 October 2026
- Published by Wiley in Journal of Medical Virology
- Vol. 98 (11) , e71201
Plasma Interleukin‐10 Levels and IL10 Genetic Variants Are Associated With Clinical Outcomes in Patients With Severe COVID‐19 Treated With Corticosteroids
We aimed to evaluate the association between IL10 variants and plasma IL‐10 levels and clinical outcomes in patients with severe COVID‐19 treated with corticosteroids. We studied 944 patients with severe COVID‐19 who were treated with corticosteroids. The clinical outcomes evaluated were in‐hospital mortality and the requirement of invasive mechanical ventilation (IMV). The variants IL10 rs1800872, rs1554286, rs3024505, and rs3122605 were determined using TaqMan SNP assays, and IL‐10 levels were measured by ELISA at the start of corticosteroid treatment (T1) and after 8 days (T2). The rs1800872‐TT ( p = 0.035, OR = 1.55, 95% CI = 1.03–2.33) and the rs1554286‐AA genotypes were associated with IMV ( p adj = 0.036, OR = 2.42, 95% CI = 1.12–5.95). IL‐10 levels were higher at T1 than at T2. At T2, IL‐10 levels were higher in non‐survivors (15.9 vs. 7.0 pg/mL, p < 0.001) and in patients requiring IMV (9.9 vs. 5.5 pg/mL, p < 0.001). Among non‐survivors, IL‐10 plasma levels did not decrease at T2. The alluvial plot revealed that 51.9% of patients in the highest IL‐10 tertile at T1 remained in the highest tertile at T2, with a mortality rate of 50%. IL10 rs1800872 and rs1554286 contribute to the risk of requiring IMV. Elevated IL‐10 levels after corticosteroid treatment were linked to in‐hospital mortality and IMV.
- 30 October 2026
- Published by Wiley in Journal of Medical Virology
- Vol. 98 (11) , e71201
Open AccessPlasma Interleukin‐10 Levels and IL10 Genetic Variants Are Associated With Clinical Outcomes in Patients With Severe COVID‐19 Treated With Corticosteroids
We aimed to evaluate the association between IL10 variants and plasma IL‐10 levels and clinical outcomes in patients with severe COVID‐19 treated with corticosteroids. We studied 944 patients with severe COVID‐19 who were treated with corticosteroids. The clinical outcomes evaluated were in‐hospital mortality and the requirement of invasive mechanical ventilation (IMV). The variants IL10 rs1800872, rs1554286, rs3024505, and rs3122605 were determined using TaqMan SNP assays, and IL‐10 levels were measured by ELISA at the start of corticosteroid treatment (T1) and after 8 days (T2). The rs1800872‐TT ( p = 0.035, OR = 1.55, 95% CI = 1.03–2.33) and the rs1554286‐AA genotypes were associated with IMV ( p adj = 0.036, OR = 2.42, 95% CI = 1.12–5.95). IL‐10 levels were higher at T1 than at T2. At T2, IL‐10 levels were higher in non‐survivors (15.9 vs. 7.0 pg/mL, p < 0.001) and in patients requiring IMV (9.9 vs. 5.5 pg/mL, p < 0.001). Among non‐survivors, IL‐10 plasma levels did not decrease at T2. The alluvial plot revealed that 51.9% of patients in the highest IL‐10 tertile at T1 remained in the highest tertile at T2, with a mortality rate of 50%. IL10 rs1800872 and rs1554286 contribute to the risk of requiring IMV. Elevated IL‐10 levels after corticosteroid treatment were linked to in‐hospital mortality and IMV.
- 27 February 2026
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 71 (6) , 753-761.e3
Geriatric Vulnerability and Symptom Burden as Determinants of Palliative Care in Respiratory Disease
- 27 February 2026
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 71 (6) , 753-761.e3
Geriatric Vulnerability and Symptom Burden as Determinants of Palliative Care in Respiratory Disease
- Open Access
- 1 October 2025
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 18, 14841-14855
OPG and TNFR1 as Potential Biomarkers of Inflammation in Older Adults with Acute COVID-19 and Indicators of Frailty in Post-COVID-19: A Pilot Study
Background: Older individuals are at high risk for severe COVID-19 and often experience geriatric syndromes as post-COVID-19 sequelae associated with inflammation. Osteoprotegerin (OPG) and Tumor Necrosis Factor Receptor 1 (TNFR1) are emerging as promising biomarkers in inflammation-associated diseases. Here, these and other members of the tumor necrosis factor superfamily (TNFSF) were investigated as potential biomarkers to monitor older adults during acute COVID-19 and post-COVID-19 recovery. Patients and Methods: This study included 75 patients with acute COVID-19, 26 post-COVID-19 (evaluated at 4 and 12 months), 35 healthy donors (HD), and 36 individuals with interstitial lung diseases (ILD), all aged over 60. Plasma levels of 14 soluble TNFSF members were measured using flow cytometry-based multiplex immunoassays and ELISA. Multiple logistic regression and ROC curve analyses were performed to assess the potential of TNFSF members as biomarkers. Results: Flow cytometry revealed significantly higher levels of OPG, BAFF, and APRIL in acute COVID-19 patients than in HD and ILD (p< 0.001). Through an ELISA, high levels of OPG (p< 0.0001), APRIL (p< 0.05), and BAFF (p< 0.0001) were confirmed, and TNFR1 (p< 0.0001) was also revealed. In this pilot study, OPG and TNFR1 had AUCs > 0.90 and were predictive of COVID-19, independent of comorbidities, while BAFF levels were modified by diabetes. Persistently elevated OPG and TNFR1 levels were also observed in post-COVID-19 patients at 4 and 12 months. Notably, OPG levels were higher in frail versus non-frail individuals at both time points (p< 0.05), while TNFR1 levels were higher only at 4 months (p< 0.05). Conclusion: This evidence indicates that OPG and TNFR1 are potential biomarkers of inflammation during acute COVID-19 and post-COVID-19 among older, mainly frail adults. These findings support their utility in managing post-COVID-19 geriatric frailty syndrome.
- 1 October 2025
- Published by Taylor & Francis in Journal of Inflammation Research
- Vol. ume 18, 14841-14855
Open AccessOPG and TNFR1 as Potential Biomarkers of Inflammation in Older Adults with Acute COVID-19 and Indicators of Frailty in Post-COVID-19: A Pilot Study
Background: Older individuals are at high risk for severe COVID-19 and often experience geriatric syndromes as post-COVID-19 sequelae associated with inflammation. Osteoprotegerin (OPG) and Tumor Necrosis Factor Receptor 1 (TNFR1) are emerging as promising biomarkers in inflammation-associated diseases. Here, these and other members of the tumor necrosis factor superfamily (TNFSF) were investigated as potential biomarkers to monitor older adults during acute COVID-19 and post-COVID-19 recovery. Patients and Methods: This study included 75 patients with acute COVID-19, 26 post-COVID-19 (evaluated at 4 and 12 months), 35 healthy donors (HD), and 36 individuals with interstitial lung diseases (ILD), all aged over 60. Plasma levels of 14 soluble TNFSF members were measured using flow cytometry-based multiplex immunoassays and ELISA. Multiple logistic regression and ROC curve analyses were performed to assess the potential of TNFSF members as biomarkers. Results: Flow cytometry revealed significantly higher levels of OPG, BAFF, and APRIL in acute COVID-19 patients than in HD and ILD (p< 0.001). Through an ELISA, high levels of OPG (p< 0.0001), APRIL (p< 0.05), and BAFF (p< 0.0001) were confirmed, and TNFR1 (p< 0.0001) was also revealed. In this pilot study, OPG and TNFR1 had AUCs > 0.90 and were predictive of COVID-19, independent of comorbidities, while BAFF levels were modified by diabetes. Persistently elevated OPG and TNFR1 levels were also observed in post-COVID-19 patients at 4 and 12 months. Notably, OPG levels were higher in frail versus non-frail individuals at both time points (p< 0.05), while TNFR1 levels were higher only at 4 months (p< 0.05). Conclusion: This evidence indicates that OPG and TNFR1 are potential biomarkers of inflammation during acute COVID-19 and post-COVID-19 among older, mainly frail adults. These findings support their utility in managing post-COVID-19 geriatric frailty syndrome.
- 14 September 2024
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 64 (suppl 68) , PA5315
Inflammatory mediators and lung function in older COVID-19 survivors.
Background: Severe COVID-19 in older adults is associated with multisystemic inflammation, leading to poor outcomes. The long-term consequences and how subacute inflammation affects pulmonary function remain unclear. Aim: to analyze the relationship between inflammatory cytokines four months after discharge and lung function one year later in severe COVID-19 older survivors, and the influence of steroid use in their performance. Methods: Twenty patients, predominantly female, were recruited from a specialized Post-COVID Care Clinic. Blood samples were collected four months after discharge, and flow cytometry was performed to measure intracellular cytokines in CD4+ T-cells. Pulmonary function tests were conducted one-year post-discharge. A Pearson correlation was done to assess the relationship between cytokine levels and pulmonary function. Results: At the four-month assessment, it was observed that patients exhibiting CD4+ T cells expressing IFN-γ (rho −0.673, p=0.008), IL-10 (rho −0.705, p=0.007), and IL-4 (rho −0.716, p=0.013) displayed a negative correlation with DLCO levels at the one-year follow-up. Conclusions: There is a statistically significant correlation between intracellular cytokines and reduced pulmonary function, particularly DLCO, at the one-year mark. Detection of inflammatory mediators four months after discharge from critical illness can help anticipate long-term pulmonary impairment in older survivors. Fig 1. Inverse correlation between four-months intracellular cytokines and one-year pulmonary function test in older adults who survived COVID-19
- 14 September 2024
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 64 (suppl 68) , PA5315
Inflammatory mediators and lung function in older COVID-19 survivors.
Background: Severe COVID-19 in older adults is associated with multisystemic inflammation, leading to poor outcomes. The long-term consequences and how subacute inflammation affects pulmonary function remain unclear. Aim: to analyze the relationship between inflammatory cytokines four months after discharge and lung function one year later in severe COVID-19 older survivors, and the influence of steroid use in their performance. Methods: Twenty patients, predominantly female, were recruited from a specialized Post-COVID Care Clinic. Blood samples were collected four months after discharge, and flow cytometry was performed to measure intracellular cytokines in CD4+ T-cells. Pulmonary function tests were conducted one-year post-discharge. A Pearson correlation was done to assess the relationship between cytokine levels and pulmonary function. Results: At the four-month assessment, it was observed that patients exhibiting CD4+ T cells expressing IFN-γ (rho −0.673, p=0.008), IL-10 (rho −0.705, p=0.007), and IL-4 (rho −0.716, p=0.013) displayed a negative correlation with DLCO levels at the one-year follow-up. Conclusions: There is a statistically significant correlation between intracellular cytokines and reduced pulmonary function, particularly DLCO, at the one-year mark. Detection of inflammatory mediators four months after discharge from critical illness can help anticipate long-term pulmonary impairment in older survivors. Fig 1. Inverse correlation between four-months intracellular cytokines and one-year pulmonary function test in older adults who survived COVID-19
- Open Access
- 19 April 2024
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 10 (4)
Enhancing quality of life in severe post-COVID-19 survivors through multidisciplinary care
Background: COVID-19 survivors who were hospitalised continue to experience long-term multisystemic sequelae and symptoms, impacting their health-related quality of life (HRQoL). The complexity of post-COVID-19 conditions underscores the importance of adopting a multidisciplinary, patient-centric approach to ensure ongoing care. This study aims to assess HRQoL and post-COVID symptoms in a cohort of severe COVID-19 survivors depending on their participation in a multidisciplinary programme.Methods: This prospective study was conducted in a post-COVID clinic staffed by a multidisciplinary team (physical rehabilitator, nutritionist, psychologist, including experts in pulmonary rehabilitation, nutrition, psychology and others). Subjects over 18 years old who were hospitalised due to severe COVID-19 during the acute phase and had attended the post-COVID clinic within the first 3 months following discharge were included. Subjects who were unable or unwilling to provide informed consent to participate in the protocol were excluded. Linear mixed-effect models were employed to examine changes in 12-Item Short-Form Health Survey (SF-12) component scores. The resolution of post-COVID symptom clusters was compared using the Cox model.Results: A total of 730 patients were included, with a mean±sdage of 55.78±15.43 years; 60.55% were male and 90.62% required mechanical ventilation during hospitalisation. Programme attendants demonstrated improved SF-12 physical and mental component scores at 3 and 12 months. A reduction in the prevalence of post-COVID symptoms was observed in both groups, with greater reductions in those attending the programme.Conclusion: Our study showed that patients enrolled on the multidisciplinary programme experienced improvements in fatigue, musculoskeletal, gastrointestinal, neuropsychiatric and respiratory symptoms, along with enhanced SF-12 mental and physical component scores.
- 19 April 2024
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 10 (4)
Open AccessEnhancing quality of life in severe post-COVID-19 survivors through multidisciplinary care
Background: COVID-19 survivors who were hospitalised continue to experience long-term multisystemic sequelae and symptoms, impacting their health-related quality of life (HRQoL). The complexity of post-COVID-19 conditions underscores the importance of adopting a multidisciplinary, patient-centric approach to ensure ongoing care. This study aims to assess HRQoL and post-COVID symptoms in a cohort of severe COVID-19 survivors depending on their participation in a multidisciplinary programme.Methods: This prospective study was conducted in a post-COVID clinic staffed by a multidisciplinary team (physical rehabilitator, nutritionist, psychologist, including experts in pulmonary rehabilitation, nutrition, psychology and others). Subjects over 18 years old who were hospitalised due to severe COVID-19 during the acute phase and had attended the post-COVID clinic within the first 3 months following discharge were included. Subjects who were unable or unwilling to provide informed consent to participate in the protocol were excluded. Linear mixed-effect models were employed to examine changes in 12-Item Short-Form Health Survey (SF-12) component scores. The resolution of post-COVID symptom clusters was compared using the Cox model.Results: A total of 730 patients were included, with a mean±sdage of 55.78±15.43 years; 60.55% were male and 90.62% required mechanical ventilation during hospitalisation. Programme attendants demonstrated improved SF-12 physical and mental component scores at 3 and 12 months. A reduction in the prevalence of post-COVID symptoms was observed in both groups, with greater reductions in those attending the programme.Conclusion: Our study showed that patients enrolled on the multidisciplinary programme experienced improvements in fatigue, musculoskeletal, gastrointestinal, neuropsychiatric and respiratory symptoms, along with enhanced SF-12 mental and physical component scores.
- Open Access
- 12 November 2023
- Published by Wiley in Aging Medicine
- Vol. 6 (4) , 353-360
Geriatric care‐related outcomes in patients 75 years and older admitted to a pulmonary disease center and predictors for hospital‐related complications
Objective: The primary aim of this study was to evaluate the influence of targeted interventions, administered through comprehensive geriatric assessments on the incidence of hospitalization‐related complications among older adults diagnosed with pulmonary diseases.Methods: A retrospective analysis of medical records encompassed individuals aged 75 years and older who were admitted to a lung center during the period spanning from March to June 2023. These admissions occurred in a context where standardized geriatric management protocols were systematically implemented. This study's scope extended to assessing the prevalence of hospital‐related complications, encompassing delirium and pressure ulcers. A rigorous multivariate logistic regression analysis was conducted to discern and characterize associated factors.Results: The integration of comprehensive geriatric assessment yielded a substantial reduction in in‐hospital complications among the cohort of 118 patients (mean age : 82.1 ± 5.6 years, 44.5% women). The incidence of delirium decreased from 53.3% to 21.8% [odds ratio (OR): 0.246, 95% confidence interval (CI): 0.134–0.450, p < 0.001], whereas the presence of pressure ulcers decreased from 43.9% to 25% (OR: 0.395, 95% CI: 0.217–0.715, p < 0.001). The multivariate analysis uncovered independent associations between delirium and variables including community‐acquired pneumonia (OR: 4.417, 95% CI : 1.574–12.395, p = 0.005), severe disability (OR: 2.981, 95% CI: 1.140–7.798, p = 0.026), and hearing loss (OR: 3.219, 95% CI : 1.260–8.170, p = 0.014). Prolonged hospital stays emerged as the sole factor significantly associated with pressure ulcers (OR: 1.071, 95% CI: 1.033–1.109). Furthermore, an intricate bidirectional relationship was evident between delirium and pressure ulcers (OR: 7.158, 95% CI: 2.962–17.300, p < 0.01).Conclusion: In conjunction with its consequent interventions, geriatric evaluation assumes a pivotal role in ameliorating adverse outcomes stemming from hospitalization among older adults afflicted with pulmonary ailments. This role gains particular salience among subpopulations characterized by heightened susceptibility, such as individuals coping with hearing loss and severe disability.
- 12 November 2023
- Published by Wiley in Aging Medicine
- Vol. 6 (4) , 353-360
Open AccessGeriatric care‐related outcomes in patients 75 years and older admitted to a pulmonary disease center and predictors for hospital‐related complications
Objective: The primary aim of this study was to evaluate the influence of targeted interventions, administered through comprehensive geriatric assessments on the incidence of hospitalization‐related complications among older adults diagnosed with pulmonary diseases.Methods: A retrospective analysis of medical records encompassed individuals aged 75 years and older who were admitted to a lung center during the period spanning from March to June 2023. These admissions occurred in a context where standardized geriatric management protocols were systematically implemented. This study's scope extended to assessing the prevalence of hospital‐related complications, encompassing delirium and pressure ulcers. A rigorous multivariate logistic regression analysis was conducted to discern and characterize associated factors.Results: The integration of comprehensive geriatric assessment yielded a substantial reduction in in‐hospital complications among the cohort of 118 patients (mean age : 82.1 ± 5.6 years, 44.5% women). The incidence of delirium decreased from 53.3% to 21.8% [odds ratio (OR): 0.246, 95% confidence interval (CI): 0.134–0.450, p < 0.001], whereas the presence of pressure ulcers decreased from 43.9% to 25% (OR: 0.395, 95% CI: 0.217–0.715, p < 0.001). The multivariate analysis uncovered independent associations between delirium and variables including community‐acquired pneumonia (OR: 4.417, 95% CI : 1.574–12.395, p = 0.005), severe disability (OR: 2.981, 95% CI: 1.140–7.798, p = 0.026), and hearing loss (OR: 3.219, 95% CI : 1.260–8.170, p = 0.014). Prolonged hospital stays emerged as the sole factor significantly associated with pressure ulcers (OR: 1.071, 95% CI: 1.033–1.109). Furthermore, an intricate bidirectional relationship was evident between delirium and pressure ulcers (OR: 7.158, 95% CI: 2.962–17.300, p < 0.01).Conclusion: In conjunction with its consequent interventions, geriatric evaluation assumes a pivotal role in ameliorating adverse outcomes stemming from hospitalization among older adults afflicted with pulmonary ailments. This role gains particular salience among subpopulations characterized by heightened susceptibility, such as individuals coping with hearing loss and severe disability.
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , PA4418
Association of Th1/Th2 phenotype with changes in the frailty status among COVID-19 older survivors
Background: Aging is associated with persistent chronic inflammation and impairment in T cell responses, predisposing severe disease and mortality due to COVID-19 in the acute phase, and a more significant long-term burden of chronic diseases and frailty. Aims: To identify the association between T cell function and improving or worsening the frailty status at 4 and 12 months of follow-up by assessing cell proliferation and cytokine production. Methods: A cohort study of 60+ years old individuals (n=15) recruited four months after discharging due to severe COVID-19 and re-assessed at 12 months. Frailty was assessed through Fried´s phenotype criteria, and T cell subtypes were analyzed using flow cytometry. Two-way ANOVA was performed to detect the association between changes in the frailty status between both assessments and the activation phenotype of T helper cells. Results: Older adults who worsened their frailty status had a lower proportion of naïve T cells on the first assessment (fig. 1) and more outstanding production of proinflammatory cytokines such as INF-G at one year of follow-up (fig. 2). Patients who improved had lower TNF-a production at four months, less production of the suppressor cytokine IL-10, and a preserved Th1/Th2 proportion on the second assessment. Conclusions: COVID-19 older survivors who improve their frailty status at one year of follow-up have a preserved Th1/Th2 phenotype; nevertheless, those who worsen have more outstanding proinflammatory cytokine production.
- 9 September 2023
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 62 (suppl 67) , PA4418
Association of Th1/Th2 phenotype with changes in the frailty status among COVID-19 older survivors
Background: Aging is associated with persistent chronic inflammation and impairment in T cell responses, predisposing severe disease and mortality due to COVID-19 in the acute phase, and a more significant long-term burden of chronic diseases and frailty. Aims: To identify the association between T cell function and improving or worsening the frailty status at 4 and 12 months of follow-up by assessing cell proliferation and cytokine production. Methods: A cohort study of 60+ years old individuals (n=15) recruited four months after discharging due to severe COVID-19 and re-assessed at 12 months. Frailty was assessed through Fried´s phenotype criteria, and T cell subtypes were analyzed using flow cytometry. Two-way ANOVA was performed to detect the association between changes in the frailty status between both assessments and the activation phenotype of T helper cells. Results: Older adults who worsened their frailty status had a lower proportion of naïve T cells on the first assessment (fig. 1) and more outstanding production of proinflammatory cytokines such as INF-G at one year of follow-up (fig. 2). Patients who improved had lower TNF-a production at four months, less production of the suppressor cytokine IL-10, and a preserved Th1/Th2 proportion on the second assessment. Conclusions: COVID-19 older survivors who improve their frailty status at one year of follow-up have a preserved Th1/Th2 phenotype; nevertheless, those who worsen have more outstanding proinflammatory cytokine production.
- 1 January 2021
- Published by Georg Thieme Verlag KG in Geriatrics Gerontology and Aging
- Vol. 15
Geriatric principles for patients with cancer
Cancer is primarily a disease of older persons. Given the heterogeneity of aging, physiological age, rather than chronological age, better expresses the cumulative effect of environmental, medical, and psychosocial stressors, which modifies life expectancy. Comprehensive geriatric assessment, a tool that helps ascertain the physiological age of older individuals, is the gold standard for assessing older adults with cancer. Several international organizations recommend using the geriatric assessment domains to identify unrecognized health problems that can interfere with treatment and predict adverse health-related outcomes, aiding complex treatment decision making. More recently, it has been shown that geriatric assessment-guided interventions improve quality of life and mitigate treatment toxicity without compromising survival. In this review, we discuss the role of comprehensive geriatric assessment in cancer care for older adults and provide the reader with useful information to assess potential treatment risks and benefits, anticipate complications, and plan interventions to better care for older people with cancer.
- 1 January 2021
- Published by Georg Thieme Verlag KG in Geriatrics Gerontology and Aging
- Vol. 15
Geriatric principles for patients with cancer
Cancer is primarily a disease of older persons. Given the heterogeneity of aging, physiological age, rather than chronological age, better expresses the cumulative effect of environmental, medical, and psychosocial stressors, which modifies life expectancy. Comprehensive geriatric assessment, a tool that helps ascertain the physiological age of older individuals, is the gold standard for assessing older adults with cancer. Several international organizations recommend using the geriatric assessment domains to identify unrecognized health problems that can interfere with treatment and predict adverse health-related outcomes, aiding complex treatment decision making. More recently, it has been shown that geriatric assessment-guided interventions improve quality of life and mitigate treatment toxicity without compromising survival. In this review, we discuss the role of comprehensive geriatric assessment in cancer care for older adults and provide the reader with useful information to assess potential treatment risks and benefits, anticipate complications, and plan interventions to better care for older people with cancer.